HBM Holdings Limited EBIT

The latest EBIT for 2142.HK is $110M as of June 2026. That compares with $-29M in the prior-year period — up 474.5% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside HBM Holdings Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 2142.HK's EBIT moved from $-29M to $110M — a 474.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HBM Holdings Limited's operating scale or balance-sheet position.

Against Healthcare companies, 2142.HK currently prints $110M for EBIT, while the sector average sits near $110B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at HBM Holdings Limited's growth, margins, and balance sheet.

A EBIT figure of $110M for 2142.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting 2142.HK's EBIT ($110M), review year-over-year change from $-29M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.